ESC 365 - Preclinical proof-of-concept study: antisense-mediated knockdown of CALM as a therapeutic strategy for calmodulinopathy

ESC Premium Access

Preclinical proof-of-concept study: antisense-mediated knockdown of CALM as a therapeutic strategy for calmodulinopathy

Session: New Insights into Arrhythmogenesis

Topic: Arrhythmias

Speaker: Mr Y. Yamamoto (Suita, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Mr Yuta Yamamoto

National Cerebral & Cardiovascular Center, Suita (Japan)

0 follower

5 more presentations in this session

Abnormal P-waves found in patients with sleep-disordered breathing are associated with triggered pro-arrhythmic activity

Speaker: Mr S. Lebek (Regensburg, DE)

Mitochondrial connexin43 affects arrhythmogenesis with modulation of mitochondrial KATP channels

Speaker: Ms M. Nishiyama (Sendai, JP)

Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of 5182 cases from long QT syndrome and Brugada syndrome consortia cohorts and gnomAD population controls

Speaker: Doctor R. Walsh (Amsterdam, NL)

A novel trigger-substrate mechanism based on clinically concealed repolarization abnormalities underlies idiopathic ventricular fibrillation

Speaker: Doctor M. Cluitmans (Maastricht, NL)

Genome-wide association study of patients with atrioventricular nodal reentry tachycardia

Speaker: Doctor L. Andreasen (Copenhagen, DK)

Access the full session

New Insights into Arrhythmogenesis

Speakers: Mr Y. Yamamoto, Mr S. Lebek, Ms M. Nishiyama, Doctor R. Walsh, Doctor M. Cluitmans...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources